Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Feld

Showing results (51-60 of 451) with videos related to

Pageof 46
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|November 22, 2020
Peri-complication diagnosis of HCV among immigrantsLauren Lapointe-Shaw, Jordan J Feld
Hepatology Communications|June 18, 2021
Key Elements on the Pathway to HCV Elimination: Lessons Learned From the AASLD HCV Special Interest Group 2020Jordan J Feld, John W Ward
Annals of Internal Medicine|December 7, 2007
Evolution of therapy for chronic hepatitis B: progressing from the simple to the complexJordan J Feld, Marc G Ghany
Current Gastroenterology Reports|January 31, 2014
Acute hepatitis C: management in the rapidly evolving world of HCVSuraj A Sharma, Jordan J Feld
Journal of Transplant Coordination : Official Publication of the North American Transplant Coordinators Organization (NATCO)|September 3, 1998
Barriers to organ donation in the Jewish communityJ Feld, P Sherbin, E Cole
Canadian Liver Journal|August 22, 2022
Hepatitis C models of care: approaches to eliminationMia J Biondi, Jordan J Feld
Seminars in Liver Disease|June 11, 2013
Does antiviral therapy for chronic hepatitis B reduce the risk of hepatocellular carcinoma?Mahmoud Abu-Amara, Jordan J Feld
Current Gastroenterology Reports|April 22, 2015
Management of HCV in cirrhosis-a rapidly evolving landscapeSuraj A Sharma, Jordan J Feld
Hepatology (Baltimore, Md.)|February 4, 2005
HCV persistence: cure is still a four letter wordJordan J Feld, T Jake Liang
Journal of Hepatology|September 20, 2016
Second generation direct-acting antivirals - Do we expect major improvements?Jordan J Feld, Graham R Foster
Pageof 46

Showing results (51-60 of 451) with videos related to

Sort By:
Pageof 46
Liver International : Official Journal of the International Association for the Study of the Liver|November 22, 2020
Peri-complication diagnosis of HCV among immigrantsLauren Lapointe-Shaw, Jordan J Feld
Hepatology Communications|June 18, 2021
Key Elements on the Pathway to HCV Elimination: Lessons Learned From the AASLD HCV Special Interest Group 2020Jordan J Feld, John W Ward
Annals of Internal Medicine|December 7, 2007
Evolution of therapy for chronic hepatitis B: progressing from the simple to the complexJordan J Feld, Marc G Ghany
Current Gastroenterology Reports|January 31, 2014
Acute hepatitis C: management in the rapidly evolving world of HCVSuraj A Sharma, Jordan J Feld
Journal of Transplant Coordination : Official Publication of the North American Transplant Coordinators Organization (NATCO)|September 3, 1998
Barriers to organ donation in the Jewish communityJ Feld, P Sherbin, E Cole
Canadian Liver Journal|August 22, 2022
Hepatitis C models of care: approaches to eliminationMia J Biondi, Jordan J Feld
Seminars in Liver Disease|June 11, 2013
Does antiviral therapy for chronic hepatitis B reduce the risk of hepatocellular carcinoma?Mahmoud Abu-Amara, Jordan J Feld
Current Gastroenterology Reports|April 22, 2015
Management of HCV in cirrhosis-a rapidly evolving landscapeSuraj A Sharma, Jordan J Feld
Hepatology (Baltimore, Md.)|February 4, 2005
HCV persistence: cure is still a four letter wordJordan J Feld, T Jake Liang
Journal of Hepatology|September 20, 2016
Second generation direct-acting antivirals - Do we expect major improvements?Jordan J Feld, Graham R Foster
Pageof 46